Viewpoint
Health Care Policy and Law
Warning Labels and Positive Labels for Pulse Oximeters
Sara Gerke, Dipl-Jur, MA; Carmel Shachar, JD, MPH
Original Investigation
Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial
Kara M. Magane, MS; Kimberly A. Dukes, PhD; Sarah Fielman, MS; et al.
Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial
Nancy A. Rigotti, MD; Neal L. Benowitz, MD; Judith J. Prochaska, PhD, MPH; et al.
Invited Commentary
Hospital-Initiated Naltrexone for Alcohol Use Disorder
Melissa B. Weimer, DO, MCR; David A. Fiellin, MD
From JAMA This Week
CONSORT 2025 Statement
Sally Hopewell, DPhil; An-Wen Chan, MD, DPhil; Gary S. Collins, PhD; et al
Comment & Response
Social Isolation and Mortality in COPD
Qiang Xie, MEd
Social Isolation and Mortality in COPD—Reply
Angela O. Suen, MD; Ashwin Kotwal, MD, MS
|